Evidence map›Paper›PMID 32721605›Full record

ReviewThe journal of allergy and clinical immunology. In practice2020

Novel Approaches to Food Allergy Management During COVID-19 Inspire Long-Term Change.

Douglas P Mack, Edmond S Chan, Marcus Shaker, Elissa M Abrams, Julie Wang, David M Fleischer, Mariam A Hanna, Matthew Greenhawt

Open access · greenAbstract readReview
In one paragraph

Review in The journal of allergy and clinical immunology. In practice, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Review
  3. Primary prevention of food allergy: beyond early introduction.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2024
    Review
  4. Article
  5. Anaphylaxis: Definition and criteria.Journal of food allergy · 2024
    Article
  6. Article
  7. Will Oral Food Challenges Still Be Part of Allergy Care in 10 Years' Time?The journal of allergy and clinical immunology. In practice · 2023
    Review
  8. Geographical discrepancy in oral food challenge utilization based on Canadian billing data.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2023
    Article
  9. Paediatrics & child health · 2022
    Article
  10. Psychological impacts of coronavirus disease 2019 on people with asthma, allergic rhinitis, and food allergy.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2022
    Review
  11. Article
  12. Patient selection for milk and egg ladders using a food ladder safety checklist.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2022
    Article
  13. Article
  14. Review
  15. Home epinephrine-treated reactions in food allergy oral immunotherapy: Lessons from the coronavirus disease 2019 lockdown.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2021
    Article
  16. Practical challenges in oral immunotherapy resolved through patient-centered care.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2021
    Review
  17. Management of Allergic Diseases During COVID-19 Outbreak.Current allergy and asthma reports · 2021
    Review
  18. What the COVID-19 Pandemic Can Teach Us About Resource Stewardship and Quality in Health Care.The journal of allergy and clinical immunology. In practice · 2021
    Article
  19. Management of Anaphylaxis During the SARS-CoV-2 Pandemic.Current treatment options in allergy · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 2 countries.

Douglas P MackDepartment of Pediatrics, McMaster University, Hamilton, Ontario, Canada. Electronic address: dougpmack@gmail.com.
Edmond S ChanDepartment of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada.
Marcus ShakerSection of Allergy and Immunology, Dartmouth-Hitchcock Medical Center, Lebanon, NH; Department of Pediatrics, Geisel School of Medicine at Dartmouth, Hanover, NH.
Elissa M AbramsDepartment of Pediatrics, University of Manitoba, Winnipeg, Manitoba, Canada.
Julie WangDivision of Allergy and Immunology, Jaffe Food Allergy Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
David M FleischerSection of Allergy and Immunology, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, Colo.
Mariam A HannaDepartment of Pediatrics, McMaster University, Hamilton, Ontario, Canada.
Matthew GreenhawtSection of Allergy and Immunology, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, Colo.
McMaster University · CAChildren's Hospital Colorado · USDartmouth–Hitchcock Medical Center · USIcahn School of Medicine at Mount Sinai · USUniversity of British Columbia · CAUniversity of Colorado Denver · USUniversity of Manitoba · CA

Funding

Determining Tradeoffs Among Health Benefits, Adverse Events, and Resource Use Associated with Food Allergy TreatmentK08HS024599 · AHRQ · UNIVERSITY OF COLORADO DENVER · PI GREENHAWT, MATTHEW JASON · 2016 to 2018
$450k
AHRQ HHS K08 HS024599
6 · The paper itself

Abstract

The SARS-CoV2 pandemic has prompted a re-evaluation of our current practice of medicine. The seemingly abrupt worldwide spread of this disease resulted in immediate changes and a reduction in many allergy-focussed services and procedures. The reality of the long-term circulation of this virus in our communities requires us to evolve as a specialty. In this article, we outline current and future challenges in the management of food allergy in light of coronavirus disease 2019 (COVID-19). We focus on infant food allergy prevention, management of anaphylaxis, accurate diagnosis with oral food challenges, and active management of food allergy with oral immunotherapy. This article identifies the challenges of conflicting guidelines, shortcomings of acute management approaches, and inherent system deficiencies. We offer perspectives and strategies that can be implemented now, including an evaluation of virtual care and telemedicine for the management of food allergy. The use of a shared decision-making model results in novel approaches that can benefit our patients and our specialty for years to come. COVID-19 has forced us to re-evaluate our current way of thinking about food allergy management to better treat our patients.

Indexed as

BetacoronavirusAnaphylaxisCoronavirus InfectionsCOVID-19Food HypersensitivityHumansImmunotherapyPandemicsPneumonia, ViralSARS-CoV-2TelemedicineAnaphylaxisCOVID-19Food allergyFood allergy preventionOral food challengesOral immunotherapyPeanut allergyTelemedicineVirtual care

Identifiers

PMID32721605
PMCPMC7382335
OpenAlexW3044029285

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.